Clinical Trial

Endothelial Dysfunction as a Predictive Marker of Acute Graft-Versus-Host Disease in Adult Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Name: Endothelial Dysfunction as a Predictive Marker of Acute Graft-Versus-Host Disease in Adult Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation — clinical trial record (NCT07508345)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: END-GAME

Completed

View on ClinicalTrials.gov →

Summary

Assess whether the CEC count in peripheral blood, analyzed at baseline T0, can predict the risk of acute GvHD onset.

Trial Details

NCT Number	NCT07508345
Lead Sponsor	Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions	GVHD
Enrollment	50 participants
Start Date	2021-06-04
Primary Completion	2022-07-31 (estimated)
Study Completion	2023-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-02